language-icon Old Web
English
Sign In
Acemap > Paper > Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer

Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer

2013 
Bicalutamide-activated oncolytic adenovirus for the adjuvant therapy of high-risk prostate cancer
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    26
    References
    3
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.